Preeclampsia and the Risk of Future Vascular Disease and Mortality: A Review

Journal of Midwifery and Women's Health

Volumn 61, Issue 3, 2016, Pages 315-324

  Leslie, Mayri Sagady ^a   Briggs, Linda A ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Obstetric complications; Patient education; Postpartum care; Preventative health care; Primary care; Systematic reviews and meta analyses

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; HUMAN; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PEER REVIEW; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; CARDIOVASCULAR DISEASES; FEMALE; MORTALITY; PRE-ECLAMPSIA; PREGNANCY;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 84970021138     PISSN: 15269523     EISSN: 15422011     Source Type: Journal    
DOI: 10.1111/jmwh.12469     Document Type: Review

References (59)

1. Young B, Hacker MR, Rana S. Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy. 2012;31(1):50-58.
2. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: Age-period-cohort analysis. BMJ. 2013;347:f6564.
3. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122-1131.
4. Adams EM, MacGillivray I. Long-term effect of preeclampsia on blood-pressure. Lancet. 1961;2(7217):1373-1375.
5. Schmittdiel J, Selby JV, Swain B, et al. Missed opportunities in cardiovascular disease prevention? Low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. Hypertension. 2011;57:717-722.
6. Wilkins-Haug L, Celi A, Thomas A, Frolkis J, Seely EW. Recognition by women's health care providers of long-term cardiovascular disease risk after preeclampsia. Obstet Gynecol. 2015;125(6):1287-1292.
7. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update. Journal of the American College of Cardiology. 2011;57(12):1404-1423.
8. National Collaborating Centre for Women's and Children's Health. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. 2010.
9. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation. 2011;123(4):e18-e209.
10. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation. 2014;129(3):e28-e292.
11. Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA, American Heart Association Cardiovascular Disease and Stroke in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on High Blood Pressure Research and Council on Nutrition, Physical Activity and Metabolism. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation. 2013;127(11):1254-1263, e1-e29.
12. Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499-510.
13. Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention. Women and heart disease fact sheet. http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_women_heart.htm. Updated November 30, 2015.
14. Chen CW, Jaffe IZ, Karumanchi SA, Chen CW, Jaffe IZ, Karumanchi, SA (2014). Pre-eclampsia and cardiovascular disease. 101(4), 579-586. Cardiovasc Res.
15. Redman CW, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol. 2007;76(1-2):61-67.
16. Faas MM, Spaans F, De Vos P. Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol. 2014;5:298.
17. Roberts JM, Hubel CA. The two stage model of preeclampsia: Variations on the theme. Placenta. 2009;30(suppl A):S32-S37.
18. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta. 2009;30(suppl A):S43-S38.
19. Hall JE. Lipid metabolism. In: Hall JE, ed. Guyton and Hall textbook of medical physiology. 13th ed. Philadelphia, PA: Elsevier; 2016. https://www-clinicalkey-com.proxygw.wrlc.org/#!/content/book/3-s2.0-B978145577005200069X.
20. Brashers VL. Alterations in cardiovascular function. In: McCance KL, Huether SE, eds. Pathophysiology: The biologic basis for disease in adults and children . 6th ed. Philadelphia, PA: Elsevier-Mosby; 2010:1157-1159.
21. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation. 2007;115(10):1285-1295.
22. Taddei S, Ghiadoni L, Virdis A, Versari D, Salvetti A. Mechanisms of endothelial dysfunction: Clinical significance and preventive non-pharmacological therapeutic strategies. Curr Pharm Des. 2003;9(29):2385-2402.
23. Ostlund E, Al-Nashi M, Hamad RR, et al. Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypertens Res. 2013;36(12):1081-1087.
24. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.
25. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: Systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1-19.
26. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918-930.
27. Kung J, Chiappelli F, Cajulis OO, et al. From systematic reviews to clinical recommendations for evidence-based health care: Validation of revised assessment of multiple systematic reviews (R-AMSTAR) for grading of clinical relevance. Open Dent J. 2010;4:84-91.
28. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7(10).
29. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-1012.
30. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin J. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):ix-xiv.
31. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-e322.
32. Cirillo PM, Cohn BA. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the child health and development studies pregnancy cohort. Circulation. 2015;132(13):1234-1242.
33. Tranquilli AL. Introduction to ISSHP new classification of preeclampsia. Pregnancy Hypertens. 2013;3(2):58-59.
34. Berends AL, de Groot CJ, Sijbrands EJ, et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension. 2008;51(4):1034-1041.
35. Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Davey Smith G, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ. 2007;335:978-981.
36. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791-798.
37. Meher S, Duley L. Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev. 2006(2):CD005939.
38. Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2)(2):CD006490. doi: 10.1002/14651858.CD006490.
39. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev. 2008;(1):CD004227.
40. Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497-506.
41. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25)(suppl 2):S76-S99.
42. Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev. 2007(1):CD004451.
43. Hofmeyr GJ, Lawrie TA, Atallah AN, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;6:CD001059.
44. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;2(2):CD004659.
45. United States Preventative Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/low-dose-aspirin-use-for-the-prevention-ofmorbidity-and-mortality-from-preeclampsia-preventive-medication. Updated 2014.
46. Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(5):1545-1588.
47. Ehrenthal DB, Catov JM. Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention. Curr Opin Cardiol. 2013;28(5):547-553.
48. Lewis BG, Halm EA, Marcus SM, Korenstein D, Federman AD. Preventive services use among women seen by gynecologists, general medical physicians, or both. Obstet Gynecol. 2008;111(4):945-952.
49. Spaan J. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension. 2012;60(6):1368-1373.
50. Berks D, Hoedjes M, Raat H, Duvekot JJ, Steegers EA, Habbema JD. Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: A literature-based study. BJOG. 2013;120(8):924-931.
51. Goff DCJ, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25)(suppl 2):S49-S73.
52. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985-3023.
53. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-2934.
54. Mehta PK, Minissian M, Bairey Merz CN. Adverse pregnancy outcomes and cardiovascular risk factor management. Semin Perinatol. 2015;39(4):268-275.
55. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
56. American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care. 2015;38(suppl):S77-S79.
57. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066-3072.
58. Stekkinger E, Zandstra M, Peeters LL, Spaanderman ME. Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome. Obstet Gynecol. 2009;114(5):1076-1084.
59. Preeclampsia Foundation. Heart disease and stroke. http://www.preeclampsia.org/health-information/heart-disease-stroke. Updated 2015.